drugset / Trial / NCT06396390

Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes

NCT06396390

Phase 4 Not yet recruiting 152 enrolled Nesta Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this randomized clinical trial is to compare the effects of two different ovarian stimulation methods: Progestin Primed Ovarian Stimulation (PPOS) vs. GnRH Antagonist in embryologic outcomes of IVF Patients.

Timeline

Start
2024-08-01
Primary completion
2026-06-01
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cetrorelix Other / unclassified 250 ug/ml Subcutaneous
Subject Dydrogesterone Other / unclassified 10 mg Oral
Background Choriogonadotropin-α Unknown 250 ug Subcutaneous
Background Triptorelin Other / unclassified 0.1 mg/ml Subcutaneous

Indications